If you are having trouble reading this email, read the web browser version.

BIOBETTERS AND NEXT-GENERATION BIOLOGICS:
Innovative Strategies for Optimally Effective Therapies

Scientific Organizers:
Cherié L. Butts, Amy S. Rosenberg,
Amy D. Klion and Sachdev S. Sidhu

Date Dates:
January 22-26, 2017

Location Location:
Snowbird, Utah, USA
Submit abstracts for short talk consideration by October 20, 2016.
SUBMIT ABSTRACT

Join us for this four-day conference whose goal is to examine different approaches for treatment of cancer and other diseases such as fibrosis, autoimmunity and inflammatory diseases. The program will provide insights from academic and industry scientists on innovative biologics technologies and treatment strategies for ameliorating disease in an effort to identify synergies and opportunities to cross-fertilize approaches. Furthermore, the meeting includes perspectives from the US Food & Drug Administration and how the outlined strategies will impact the drug review and approval process. The intention is to better inform meeting attendees of current/future strategies for treating disease and best practices for transforming concepts into approved drugs.

In summary, this conference will:

  • Provide a forum for discussing cutting-edge biologics technologies and experimental approaches to treating diseases associated with aberrant immune responses, including cancer, autoimmune and inflammatory conditions;
  • Highlight elements of drug/biologics applications that may delay approval, including perspectives from a regulatory agency on discrepancies in biologics applications and challenges with new models;
  • Consider the future direction of biologics technologies and identify the most relevant unanswered questions, areas requiring more focus, and those that would benefit from new approaches in related fields.
The conference will consist of sessions focused on the following topics:

  • Modified and Alternative Scaffolds as Novel Biotherapeutics
  • Non-Antibody Scaffolds, Microenvironment Modulators
  • Enhancing Activity/Reducing Immunogenicity
  • Tissue-Specific Targeting/Strategies for PK Optimization
  • Bispecific and Antibody-Drug Conjugates
  • Different Approaches to Targeting Tumors: Melanoma as an Example
  • Biologics in Autoimmunity/Autoinflammatory Disorders
  • Multimodal Approaches to Allergic Inflammation
  • Concept to Clinic to Market

The conference will bring together a broad community of researchers from academia, pharma and government. In particular, it will be of value to those working in the fields of:

Cancer • Immunology • Autoimmunity • Allergy •
Drug Discovery

REGISTER FOR THE CONFERENCE
DOWNLOAD CONFERENCE FLYER

Keystone Symposia conferences offer:

  • A retreat-like atmosphere
  • An intimate environment
  • Interactive poster sessions
  • Exchange of ideas and experiences
  • Access to experts during and after talks
  • Short talk slots for breakthroughs and up-and-coming/junior investigators
  • Free time for recreation and collaboration-building
ADD SYMPOSIA DEADLINES TO CALENDAR

Confirmed Speakers
(as of Oct 5, 2016)

John C. Bell, Ottawa Hospital Research Institute, Canada
Ruben Boado, ArmaGen, USA
Bruce S. Bochner, Northwestern University Feinberg School of Medicine, USA
Stylianos Bournazos, Rockefeller University, USA
Pierre Bruhns, Institut Pasteur, France
Cherié L. Butts, Biogen, USA
Jennifer R. Cochran, Stanford University, USA
Nancy M. Dahms, Medical College of Wisconsin, USA
Anne S. De Groot, EpiVax, Inc., USA
Luca Gattinoni, NCI, National Institutes of Health, USA
Raphaela Goldbach-Mansky, NIAID, National Institutes of Health, USA
Margaret Karow, Amgen Inc., USA
Amy D. Klion, NIAID, National Institutes of Health, USA
Shohei Koide, University of Chicago, USA
Réjean Lapointe, University of Montreal, CHUM, Canada
James W. Lillard, Jr., Morehouse School of Medicine, USA
Lynn E. Macdonald, Regeneron Pharmaceuticals, USA
Ariel Munitz, Tel Aviv University, Israel
Hector G. Ortega, Genentech, USA
Virginia Pascual, Baylor Research Institute, USA
Andreas G. Plückthun, University of Zürich, Switzerland
Amy S. Rosenberg, U.S. Food and Drug Administration, USA
Sachdev S. Sidhu, University of Toronto, Canada
Arne Skerra*, Technical University of Munich, Germany
Douglas E. Williams*, Codiak Biosciences, USA
Karl Dane Wittrup, Massachusetts Institute of Technology, USA

*Keynote speaker


For the most up-to-date list of speakers and talks, click here:

VIEW PROGRAM


How to Register

keystonesymposia.org/17A7

Toll-Free: 800-253-0685

Outside USA & Canada:
+1 970-262-1230

Email:
info@keystonesymposia.org


Conference Deadlines

Abstract Deadline:
Oct 20, 2016

Discounted Registration Deadline: Nov 21, 2016

Additional Information

  • Deadlines are at midnight US Mountain Time.
  • Discounted registration saves 150 USD on the later fee.
  • Short talk speakers will be chosen from abstracts received by the "Abstract Deadline" for the meeting.
  • Please note that the first advertised meeting date is the date of arrival and registration, and the last date that of the last organized sessions.

Visit our website for the program details and to plan your travel so as not to miss any sessions.

Update your account details | Unsubscribe

Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization headquartered in Colorado, USA that is directed and supported by the scientific community.
160 US Highway 6, Suite 200 | PO Box 1630 | Silverthorne, CO 80498 | USA
1-970-262-1230 | 1-800-253-0685 (in US & Canada)

Copyright © 2016 Keystone Symposia on Molecular and Cellular Biology. All rights reserved.